Altay Therapeutics logo

Altay TherapeuticsAltay develops disease-modifying therapies targeting transcription…

Altay develops small molecule drugs to treat chronic liver diseases like liver fibrosis and liver cancer. Our co-founder Dr. Osman Ozes, led the first drug development program for Esbriet (Pirfenidone), resulting in the first FDA approved therapy for lung fibrosis. Esbriet is now a $1 billion/year drug and has already made over $6 billion in revenue. With a team that has over 70+ years of small molecule drug development experience, we intend to do the same with chronic liver diseases, which affects over 20 million Americans and represents a market size of over $30 billion. We know we are well positioned for success because we have shown excellent pre-clinical mouse data in several liver fibrosis models using our novel small molecule. We demonstrate a reduction in fibrosis with our drug, but more significantly, we show a reversal in fibrotic tissue back to normal tissue. With our current developmental strategy, we hope to have a clinic-ready compound by the end of 2021 and be in phase I clinical trials by mid of 2022.

2020-03-06
Active
Early
W20
6
Healthcare
United States of AmericaAmerica / Canada
Altay Therapeutics screenshot
More About Altay Therapeutics

Altay Therapeutics: Developing Life-Saving Therapies

Introduction

Altay Therapeutics is dedicated to developing life-saving therapies by targeting disease-causing transcription factors. Our innovative approach aims to address unmet medical needs and improve patient outcomes.

Key Features

  • Cutting-edge technology targeting transcription factors
  • Robust pipeline of therapeutic candidates
  • Focus on life-saving treatments
  • Commitment to scientific excellence and innovation

Use Cases

  • Treatment of rare and complex diseases
  • Addressing unmet medical needs in various therapeutic areas
  • Providing new hope for patients with limited treatment options

Pricing

Altay Therapeutics offers competitive pricing models tailored to the needs of healthcare providers and patients. For detailed pricing information, please contact our sales team.

Teams

Our team at Altay Therapeutics comprises leading scientists, researchers, and industry experts dedicated to advancing medical science and developing breakthrough therapies. We are committed to collaboration, innovation, and excellence in all our endeavors.